Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

The global burden of renal diseases is increasingly severe, underscoring the need for in-depth exploration of the molecular mechanisms underlying renal disease progression and the development of potential novel biomarkers or therapeutic targets. Angiopoietin-like protein 4 (ANGPTL4) is a multifuncti...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Li, Yuxin Zhang, Mengxia Cao, Tingting Yuan, Santao Ou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1475198/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556662373056512
author Yan Li
Yan Li
Yan Li
Yuxin Zhang
Yuxin Zhang
Yuxin Zhang
Mengxia Cao
Mengxia Cao
Mengxia Cao
Tingting Yuan
Tingting Yuan
Tingting Yuan
Santao Ou
Santao Ou
Santao Ou
author_facet Yan Li
Yan Li
Yan Li
Yuxin Zhang
Yuxin Zhang
Yuxin Zhang
Mengxia Cao
Mengxia Cao
Mengxia Cao
Tingting Yuan
Tingting Yuan
Tingting Yuan
Santao Ou
Santao Ou
Santao Ou
author_sort Yan Li
collection DOAJ
description The global burden of renal diseases is increasingly severe, underscoring the need for in-depth exploration of the molecular mechanisms underlying renal disease progression and the development of potential novel biomarkers or therapeutic targets. Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional cytokine involved in the regulation of key biological processes, such as glucose and lipid metabolism, inflammation, vascular permeability, and angiogenesis, all of which play crucial roles in the pathogenesis of kidney diseases. Over the past 2 decades, ANGPTL4 has been regarded as playing a pivotal role in the progression of various kidney diseases, prompting significant interest from the scientific community regarding its potential clinical utility in renal disorders. This review synthesizes the available literature, provides a concise overview of the molecular biological effects of ANGPTL4, and highlights its relationship with multiple renal diseases and recent research advancements. These findings underscore the important gaps that warrant further investigation to develop novel targets for the prediction or treatment of various renal diseases.
format Article
id doaj-art-9c6f0ac53f9645dfac32cfebebf95e6f
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-9c6f0ac53f9645dfac32cfebebf95e6f2025-01-07T06:50:32ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14751981475198Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic targetYan Li0Yan Li1Yan Li2Yuxin Zhang3Yuxin Zhang4Yuxin Zhang5Mengxia Cao6Mengxia Cao7Mengxia Cao8Tingting Yuan9Tingting Yuan10Tingting Yuan11Santao Ou12Santao Ou13Santao Ou14Department of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSichuan Clinical Research Center for Nephrology, Luzhou, ChinaMetabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, ChinaDepartment of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSichuan Clinical Research Center for Nephrology, Luzhou, ChinaMetabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, ChinaDepartment of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSichuan Clinical Research Center for Nephrology, Luzhou, ChinaMetabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, ChinaDepartment of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSichuan Clinical Research Center for Nephrology, Luzhou, ChinaMetabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, ChinaDepartment of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSichuan Clinical Research Center for Nephrology, Luzhou, ChinaMetabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, ChinaThe global burden of renal diseases is increasingly severe, underscoring the need for in-depth exploration of the molecular mechanisms underlying renal disease progression and the development of potential novel biomarkers or therapeutic targets. Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional cytokine involved in the regulation of key biological processes, such as glucose and lipid metabolism, inflammation, vascular permeability, and angiogenesis, all of which play crucial roles in the pathogenesis of kidney diseases. Over the past 2 decades, ANGPTL4 has been regarded as playing a pivotal role in the progression of various kidney diseases, prompting significant interest from the scientific community regarding its potential clinical utility in renal disorders. This review synthesizes the available literature, provides a concise overview of the molecular biological effects of ANGPTL4, and highlights its relationship with multiple renal diseases and recent research advancements. These findings underscore the important gaps that warrant further investigation to develop novel targets for the prediction or treatment of various renal diseases.https://www.frontiersin.org/articles/10.3389/fphar.2024.1475198/fullangiopoietin-like protein 4renal diseasesbiomarkertherapeuticsmechanisminflammation
spellingShingle Yan Li
Yan Li
Yan Li
Yuxin Zhang
Yuxin Zhang
Yuxin Zhang
Mengxia Cao
Mengxia Cao
Mengxia Cao
Tingting Yuan
Tingting Yuan
Tingting Yuan
Santao Ou
Santao Ou
Santao Ou
Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
Frontiers in Pharmacology
angiopoietin-like protein 4
renal diseases
biomarker
therapeutics
mechanism
inflammation
title Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
title_full Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
title_fullStr Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
title_full_unstemmed Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
title_short Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
title_sort angiopoietin like protein 4 dysregulation in kidney diseases a promising biomarker and therapeutic target
topic angiopoietin-like protein 4
renal diseases
biomarker
therapeutics
mechanism
inflammation
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1475198/full
work_keys_str_mv AT yanli angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT yanli angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT yanli angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT yuxinzhang angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT yuxinzhang angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT yuxinzhang angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT mengxiacao angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT mengxiacao angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT mengxiacao angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT tingtingyuan angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT tingtingyuan angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT tingtingyuan angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT santaoou angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT santaoou angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget
AT santaoou angiopoietinlikeprotein4dysregulationinkidneydiseasesapromisingbiomarkerandtherapeutictarget